Assessing frailty at the centers for dementia and cognitive decline in Italy: potential implications for improving care of older people living with dementia.
Cognitive disorders
Dementia
Elderly
Frailty
Frailty index
Personalized medicine
Journal
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
03
03
2023
accepted:
29
05
2023
medline:
12
9
2023
pubmed:
7
6
2023
entrez:
6
6
2023
Statut:
ppublish
Résumé
Frailty is strongly associated with the clinical course of cognitive impairment and dementia, thus arguing for the need of its assessment in individuals affected by cognitive deficits. This study aimed to retrospectively evaluate frailty in patients aged 65 years and older referred to two Centers for Cognitive Decline and Dementia (CCDDs). A total of 1256 patients consecutively referred for a first visit to two CCDDs in Lombardy (Italy) between January 2021 to July 2022 were included. All patients were evaluated by an expert physician in diagnosis and care of dementia according to a standardized clinical protocol. Frailty was assessed using a 24-items Frailty Index (FI) based on routinely collected health records, excluding cognitive decline or dementia, and categorized as mild, moderate, and severe. Overall, 40% of patients were affected by mild frailty and 25% of the sample has moderate to severe frailty. The prevalence and severity of frailty increased with decreasing Mini Mental State Examination (MMSE) score and advancing age. Frailty was also detected in 60% of patients with mild cognitive impairment. Frailty is common in patients referring to CCDDs for cognitive deficits. Its systematic assessment using a FI generated with readily available medical information could help develop appropriate models of assistance and guide personalization of care.
Identifiants
pubmed: 37280476
doi: 10.1007/s10072-023-06885-8
pii: 10.1007/s10072-023-06885-8
pmc: PMC10495473
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3509-3514Informations de copyright
© 2023. The Author(s).
Références
J Alzheimers Dis. 2021;83(4):1849-1857
pubmed: 34459403
Front Med (Lausanne). 2017 Oct 23;4:178
pubmed: 29109949
Ann Ist Super Sanita. 2018 Jul-Sep;54(3):226-238
pubmed: 30284550
Geroscience. 2021 Apr;43(2):1039-1051
pubmed: 33210215
J Am Geriatr Soc. 1983 Dec;31(12):721-7
pubmed: 6418786
Sci Rep. 2023 Mar 2;13(1):3543
pubmed: 36864098
Lancet. 2019 Oct 12;394(10206):1365-1375
pubmed: 31609228
Lancet Neurol. 2019 Feb;18(2):177-184
pubmed: 30663607
Neurosci Biobehav Rev. 2019 Dec;107:96-103
pubmed: 31491474
Age Ageing. 2018 Mar 01;47(2):319
pubmed: 28100452
BMC Geriatr. 2008 Sep 30;8:24
pubmed: 18826625
Lancet. 2013 Mar 2;381(9868):752-62
pubmed: 23395245
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Gerontologist. 1969 Autumn;9(3):179-86
pubmed: 5349366
Age Ageing. 2021 Jan 8;50(1):96-104
pubmed: 33068107
Ann Intern Med. 2004 Sep 21;141(6):489-92
pubmed: 15381535
J Neurol Neurosurg Psychiatry. 2002 Oct;73(4):390-4
pubmed: 12235305
Sci Rep. 2017 Nov 16;7(1):15746
pubmed: 29146957
Am J Med. 2007 Sep;120(9):748-53
pubmed: 17765039
J Am Geriatr Soc. 2010 Apr;58(4):681-7
pubmed: 20345864
Pharmacoeconomics. 2023 Jan;41(1):59-75
pubmed: 36376775
J Am Med Dir Assoc. 2022 Nov;23(11):1807-1814
pubmed: 35283085
Eur J Neurol. 1996 May;3(3):198-202
pubmed: 21284770
Lancet. 2018 May 5;391(10132):1775-1782
pubmed: 29706364
Lancet. 2019 Oct 12;394(10206):1376-1386
pubmed: 31609229